Pharmacologic management and treatment of gastroesophageal reflux disease |
| |
Authors: | M. Storr A. Meining |
| |
Affiliation: | Department of Internal Medicine II - Standort Grosshadern, Ludwig-Maximilians University, Munich, Germany. martin.storr@med.uni-muenchen.de |
| |
Abstract: | Gastroesophageal reflux disease (GERD) is one of the most common diagnoses in daily practice. Diagnosis can be made on symptom evaluation, on pH-monitoring or on endoscopic findings. In contrast to commonly held opinion there is no strong evidence that lifestyle factors are a dominant factor in the pathophysiology of GERD. The various agents currently used for treatment of GERD include mucoprotective substances, antacids, H(2)-blockers and proton pump inhibitors. This article gives an overview of the pharmacological management of GERD and focuses on the differential therapy of endoscopy-negative GERD, GERD with esophagitis and maintenance therapy. |
| |
Keywords: | gastroesophageal reflux disease (GERD) treatment |
|
|